Free, In-Person Training
Join to learn how to address Management of Opioid Use Disorder
Hosted by: Maryland Addiction Consultation Service (MACS) and Calvert County Health Department
Audience: Primary Care Physicians, Advance Practice Registered Nurses, Physician Assistants
Learning Objectives:
- Attendees will be able to describe current procedures for initiation of buprenorphine in various settings (ED, hospital, clinic).
- Attendees will be able to describe the use of buprenorphine by Emergency medical System (EMS) personnel.
- Attendees will be able to describe current rules and regulations around the use of telemedicine to prescribe medications to treat OUD.
Presenter: Dr. Christopher Welsh, MD
Medical Consultant, Maryland Addiction Consultation Service (MACS)
Disclosure Information:
Dr. Christopher Welsh, MD, faculty for this event has reported no relevant financial relationships to disclose. The planners and reviewers for this activity have reported no relevant financial relationships to disclose.
Event contact:
MACS Training Coordinator MACSTraining@som.umaryland.edu
Event details:
Please arrive by 5:30pm for registration and dinner. The presentation will start at 6:00pm.
CME Credit: 1.0 Contact Hours
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the jointprovidership of MedChi, The Maryland State Medical Society and Maryland Addiction Consultation Services (MACS) MedChi is accredited by the ACCME to provide continuing medical education for physicians..
CEU Credit:
Maryland Addiction Consultation Service (MACS) of the University of Maryland School of Medicine, Department of Psychiatry is authorized as a sponsor of Continuing Education Units. MACS maintains responsibility for this program.
MAT and MATE Acts:
On December 29, 2022, President Biden signed the fiscal year 2023 omnibus, passing the Mainstreaming Addiction Treatment (MAT) and Medication Access and Training Expansion (MATE) Acts. These bills were passed to expand access to buprenorphine for the treatment of opioid use disorder, and normalize and enhance substance use care across healthcare settings.
MACS is monitoring guidance from state and federal agencies closely and will update this page when more information becomes available. The resources on this page offer information about the omnibus, the bills, and the implications for healthcare providers and programs. Find out more here: https://www.marylandmacs.org/mat--mate-acts/https://www.marylandmacs.org/MAT--MATE-Acts/